Speaker Profile

Ph.D., Professor and Co-founder, EarlyDiagnostics

Biography
Dr. Zhou is a co-founder of EarlyDx and a Professor of Pathology and Lab Medicine at UCLA. She has an extensive publication record in bioinformatics, big data analytics, and liquid biopsy diagnostics. She is currently leading the NIH-funded UCLA Center for the Early Detection of Liver Cancer. She previously served as the Head of Computational Biology program at University of Southern California. She is a recipient of NSF CAREER Award and Alfred Sloan Fellowship. She holds a Diplom in Biochemistry from University of Tubingen (Germany), and a Nachdiplom in Computer Science and a Ph.D. in Bioinformatics from the Swiss Federal Institute of Technology. She completed her postdoctoral training in Biostatistics at Harvard University.


Talk


Methylome-based Liquid Biopsy for Early Cancer Detection
EarlyDiagnostics’ cfMethyl-Seq technology provides cost-effective cfDNA methylome sequencing for sensitive and specific cancer detection and localization.

 Session Abstract – PMWC 2023 Silicon Valley

Track 4 - January 26 9.00 A.M.-4.30 P.M.


Track Chair: Cindy Perettie, Roche

  • PMWC 2023 Award Ceremony
    - Luis Alberto Diaz Jr., MSK
    - Razelle Kurzrock, Medical College of Wisconsin
  • Non-invasive Liquid Biopsy Techniques (PANEL)
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Apostolia Tsimberidou, MD Anderson
    - Mandana Kamgar, MD Medical College of Wisconsin
    - Mina Nikanjam, UCSD
    - Ash Alizadeh, Stanford University
  • Liquid Biopsy Challenges and Limitations (PANEL)
    Chair: Victor Lin, Mary Bird Perkins
    - Luis Alberto Diaz Jr., MSK
    - Maximilian Diehn, Stanford
    - Dana Dilbeck, Agilent
    - Emma Shtivelman, Cancer Commons
  • Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
    Chair: Cindy Perettie, Roche Diagnostics
    - Eric Peters, Genenetch
    - Andrew Mckenzie, Sarah Cannon
    - Yang Pan, Gilead
    - Alan Sandler, Mirati Therapeutics
  • Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
    Chair: Tom Beer, Exact Sceinces
  • Liquid Biopsy for Early Cancer Detection (PANEL)
    Chair: Priti Hegde, Foundation Medicine
    - Daniel Kim, UCSC
    - Mike Nolan, Freenome
    - Jeffrey Venstrom, Grail Bio
    - Kathryn Phillips, UCSF
    - Lon Castle, eviCore healthcare
    - Tom Beer, Exact Sciences
  • Liquid Biopsy for Minimal Residual Disease (PANEL)
    Chair: Minetta Liu, Natera
    - Peter Bach, Delfi diagnostics
    - Laura Vantveer, UCSF
    - Susan Bobulsky, Adaptive
    - Joshua Cohen, Johns Hopkins
  • PMWC Showcase
    - Harmeet Dhani, Biological Dynamics
    - Varsha Rao, Claret Bio
  • PMWC NCI Showcase
    - Xianghong Jasmine Zhou, EarlyDiagnostics